Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GHC Technologies was a biotechnology company based in La Jolla, California, that specialized in the development of rapid and information-rich molecular diagnostics. Founded in 2004, the company focused on creating ultrasensitive detection assays and DNA microarray technologies for both clinical point-of-care diagnostics and biodefense applications. Its technology was designed to provide fast and highly accurate identification of biological agents, leading to significant contracts with the U.S. Department of Homeland Security for programs such as rapid pathogen detection and city-wide surveillance. In 2007, GHC Technologies was acquired by ICx Technologies to bolster its portfolio of advanced biodetection solutions for military and security agencies. The company's expertise in molecular detection was subsequently integrated into next-generation biodefense products, including automated pathogen monitoring systems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GHC Technologies.